Stultiens, Johanna M. G.
Top, Wiebe M. C.
Kimenai, Dorien M.
Lehert, Philippe
Bekers, Otto
Stehouwer, Coen D. A.
Kooy, Adriaan
Meex, Steven J. R.
Clinical trials referenced in this document:
Documents that mention this clinical trial
Metformin and high-sensitivity cardiac troponin I and T trajectories in type 2 diabetes patients: a post-hoc analysis of a randomized controlled trial
https://doi.org/10.1186/s12933-022-01482-z
Funding for this research was provided by:
Health Data Research UK (HDR-5012)
Altana
Lifescan
Merck Santé
Merck Sharp and Dohme
Novo Nordisk
Article History
Received: 21 January 2022
Accepted: 10 March 2022
First Online: 4 April 2022
Declarations
:
: The medical ethical committees of the participating hospitals approved the trial protocol. The study was conducted in accordance with Good Clinical Practice (CPMP/ICH/135/95; 1996) and with the Declaration of Helsinki (revised version, 2000).
: Not applicable.
: SJRM received research grants, speaking honoraria, and consulting fees from Abbott Laboratories and Roche Diagnostics. The other authors declare that they have no competing interests.